vancomycin has been researched along with rwj 54428 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, A; Fan, AT; Glinka, TW; Hecker, SJ; Ludwikow, M; Wang, M | 1 |
| Dudley, MN; Griffith, DC; Harford, L; Lee, VJ; Williams, R | 1 |
2 other study(ies) available for vancomycin and rwj 54428
| Article | Year |
|---|---|
New anti-MRSA cephalosporins with a basic aminopyridine at the C-7 position.
Topics: Aminopyridines; Cephalosporins; Combinatorial Chemistry Techniques; Methicillin Resistance; Microbial Sensitivity Tests; Solubility; Staphylococcus aureus; Structure-Activity Relationship | 2001 |
In vivo antibacterial activity of RWJ-54428, a new cephalosporin with activity against gram-positive bacteria.
Topics: Animals; Area Under Curve; Cephalosporins; Drug Resistance, Bacterial; Gram-Positive Bacteria; Half-Life; Injections, Subcutaneous; Male; Mice; Microbial Sensitivity Tests; Models, Biological; Staphylococcal Infections; Vancomycin | 2003 |